位置:首页 > 蛋白库 > SHOT1_HUMAN
SHOT1_HUMAN
ID   SHOT1_HUMAN             Reviewed;         631 AA.
AC   A0MZ66; A8MYU7; B3KRD3; B3KRH2; B3KTE0; B3KTJ7; B3KTJ8; B4E3U1; B7Z7Z9;
AC   Q68DG1; Q6PIM5; Q9HCH4; Q9NUV0;
DT   24-JUL-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 4.
DT   03-AUG-2022, entry version 131.
DE   RecName: Full=Shootin-1 {ECO:0000312|HGNC:HGNC:29319};
DE   AltName: Full=Shootin1 {ECO:0000250|UniProtKB:A0MZ67};
GN   Name=SHTN1 {ECO:0000312|HGNC:HGNC:29319}; Synonyms=KIAA1598;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=17030985; DOI=10.1083/jcb.200604160;
RA   Toriyama M., Shimada T., Kim K.B., Mitsuba M., Nomura E., Katsuta K.,
RA   Sakumura Y., Roepstorff P., Inagaki N.;
RT   "Shootin1: a protein involved in the organization of an asymmetric signal
RT   for neuronal polarization.";
RL   J. Cell Biol. 175:147-157(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 5; 6; 7 AND 8), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 349-631 (ISOFORM 1).
RC   TISSUE=Brain, Placenta, Testis, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 388-631 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 11-631 (ISOFORM 2).
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [8]
RP   PROTEIN SEQUENCE OF 9-17; 160-169; 187-197 AND 467-479, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506; SER-515; SER-532 AND
RP   THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-249; THR-496; SER-506;
RP   SER-532 AND THR-537, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-506, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-249; SER-375; SER-473;
RP   THR-487; SER-494; SER-506; SER-532; SER-534 AND THR-537, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375; SER-494 AND SER-506, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Involved in the generation of internal asymmetric signals
CC       required for neuronal polarization and neurite outgrowth. Mediates
CC       netrin-1-induced F-actin-substrate coupling or 'clutch engagement'
CC       within the axon growth cone through activation of CDC42, RAC1 and PAK1-
CC       dependent signaling pathway, thereby converting the F-actin retrograde
CC       flow into traction forces, concomitantly with filopodium extension and
CC       axon outgrowth. Plays a role in cytoskeletal organization by regulating
CC       the subcellular localization of phosphoinositide 3-kinase (PI3K)
CC       activity at the axonal growth cone. Also plays a role in regenerative
CC       neurite outgrowth. In the developing cortex, cooperates with KIF20B to
CC       promote both the transition from the multipolar to the bipolar stage
CC       and the radial migration of cortical neurons from the ventricular zone
CC       toward the superficial layer of the neocortex. Involved in the
CC       accumulation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) in the
CC       growth cone of primary hippocampal neurons.
CC       {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- SUBUNIT: Interacts with L1CAM; this interaction occurs in axonal growth
CC       cones. Interacts with actin filament retrograde flow; this interaction
CC       is enhanced in a netrin-1- and PAK1-dependent manner and promotes F-
CC       actin-substrate coupling and concomitant formation of traction forces
CC       at axonal growth cones. Interacts with RUFY3. Interacts with PFN2.
CC       Interacts (via N-terminus) with KIF20B; this interaction is direct and
CC       promotes the association of SHTN1 to microtubules in primary neurons.
CC       Associates with microtubule. {ECO:0000250|UniProtKB:A0MZ67,
CC       ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- INTERACTION:
CC       A0MZ66; P62508: ESRRG; NbExp=3; IntAct=EBI-308778, EBI-2834260;
CC       A0MZ66; P05413: FABP3; NbExp=3; IntAct=EBI-308778, EBI-704216;
CC       A0MZ66; Q6PJR7: IGL@; NbExp=3; IntAct=EBI-308778, EBI-10254102;
CC       A0MZ66; Q9Y5B8: NME7; NbExp=3; IntAct=EBI-308778, EBI-744782;
CC       A0MZ66-4; P62508-3: ESRRG; NbExp=3; IntAct=EBI-12097232, EBI-12001340;
CC       A0MZ66-4; Q9Y2D4: EXOC6B; NbExp=3; IntAct=EBI-12097232, EBI-2690026;
CC       A0MZ66-4; P05413: FABP3; NbExp=3; IntAct=EBI-12097232, EBI-704216;
CC       A0MZ66-4; Q9Y5B8: NME7; NbExp=3; IntAct=EBI-12097232, EBI-744782;
CC       A0MZ66-4; A0MZ66-4: SHTN1; NbExp=3; IntAct=EBI-12097232, EBI-12097232;
CC       A0MZ66-4; Q15025: TNIP1; NbExp=3; IntAct=EBI-12097232, EBI-357849;
CC       A0MZ66-4; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-12097232, EBI-11952721;
CC       A0MZ66-4; Q9NP64: ZCCHC17; NbExp=3; IntAct=EBI-12097232, EBI-746345;
CC       A0MZ66-7; O75936: BBOX1; NbExp=3; IntAct=EBI-10171490, EBI-715662;
CC       A0MZ66-7; Q12800: TFCP2; NbExp=3; IntAct=EBI-10171490, EBI-717422;
CC   -!- SUBCELLULAR LOCATION: Perikaryon {ECO:0000250|UniProtKB:Q8K2Q9}. Cell
CC       projection, axon {ECO:0000250|UniProtKB:Q8K2Q9}. Cell projection,
CC       growth cone {ECO:0000250|UniProtKB:Q8K2Q9}. Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8K2Q9}. Cell projection, filopodium
CC       {ECO:0000250|UniProtKB:A0MZ67}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:A0MZ67}. Note=Localizes in multiple growth cones
CC       at neurite tips before the neuronal symmetry-breaking step. Accumulates
CC       in growth cones of a single nascent axon in a neurite length-dependent
CC       manner during the neuronal symmetry-breaking step; when absent from the
CC       nascent axon's siblings, probably due to competitive transport,
CC       prevents the formation of surplus axons. Transported anterogradely from
CC       the soma to the axon growth cone in an actin and myosin-dependent
CC       manner and passively diffuses back to the cell bodies. Colocalized with
CC       L1CAM in close apposition with actin filaments in filopodia and
CC       lamellipodia of axonal growth cones in hippocampal neurons. Exhibits
CC       retrograde movements in filopodia and lamellopodia of axonal growth
CC       cones. Colocalized with KIF20B along microtubules to the tip of the
CC       growing cone in primary hippocampal neurons. Recruited to the growth
CC       cone of developing axon in a KIF20B- and microtubule-dependent manner.
CC       {ECO:0000250|UniProtKB:A0MZ67, ECO:0000250|UniProtKB:Q8K2Q9}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=A0MZ66-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=A0MZ66-2; Sequence=VSP_027050, VSP_027051;
CC       Name=3;
CC         IsoId=A0MZ66-3; Sequence=VSP_027053;
CC       Name=4;
CC         IsoId=A0MZ66-4; Sequence=VSP_027052;
CC       Name=5;
CC         IsoId=A0MZ66-5; Sequence=VSP_036498;
CC       Name=6;
CC         IsoId=A0MZ66-6; Sequence=VSP_036499;
CC       Name=7;
CC         IsoId=A0MZ66-7; Sequence=VSP_036497;
CC       Name=8;
CC         IsoId=A0MZ66-8; Sequence=VSP_036498, VSP_027052;
CC   -!- DOMAIN: The N-terminus region is necessary for interaction with actin
CC       retrograde filament flow and accumulation in neuronal growth cones.
CC       {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- PTM: Phosphorylated on Ser-101 and Ser-249 by PAK1 through a CDC42- and
CC       RAC1-dependent signaling pathway, which enhances its association with
CC       F-actin retrograde flow in filopodia and lamellipodia of axonal growth
CC       cones. Phosphorylation on Ser-101 and Ser-249 is increased by netrin-1.
CC       {ECO:0000250|UniProtKB:A0MZ67}.
CC   -!- SIMILARITY: Belongs to the shootin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH22348.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA92019.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53052.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAG53110.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF055487; ABK56022.1; -; mRNA.
DR   EMBL; AK001984; BAA92019.1; ALT_INIT; mRNA.
DR   EMBL; AK091381; BAG52345.1; -; mRNA.
DR   EMBL; AK091578; BAG52384.1; -; mRNA.
DR   EMBL; AK095419; BAG53052.1; ALT_INIT; mRNA.
DR   EMBL; AK095703; BAG53109.1; -; mRNA.
DR   EMBL; AK095709; BAG53110.1; ALT_INIT; mRNA.
DR   EMBL; AK302705; BAH13785.1; -; mRNA.
DR   EMBL; AK304865; BAG65603.1; -; mRNA.
DR   EMBL; CR749417; CAH18259.1; -; mRNA.
DR   EMBL; AC012308; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL731557; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471066; EAW49434.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW49438.1; -; Genomic_DNA.
DR   EMBL; BC022348; AAH22348.1; ALT_INIT; mRNA.
DR   EMBL; BC032303; AAH32303.1; -; mRNA.
DR   EMBL; AB046818; BAB13424.1; -; mRNA.
DR   CCDS; CCDS31293.1; -. [A0MZ66-2]
DR   CCDS; CCDS44482.1; -. [A0MZ66-1]
DR   CCDS; CCDS58097.1; -. [A0MZ66-8]
DR   CCDS; CCDS73207.1; -. [A0MZ66-5]
DR   CCDS; CCDS73208.1; -. [A0MZ66-4]
DR   RefSeq; NP_001120683.1; NM_001127211.2. [A0MZ66-1]
DR   RefSeq; NP_001245227.1; NM_001258298.1. [A0MZ66-5]
DR   RefSeq; NP_001245228.1; NM_001258299.1. [A0MZ66-4]
DR   RefSeq; NP_001245229.1; NM_001258300.1. [A0MZ66-8]
DR   RefSeq; NP_060800.2; NM_018330.6. [A0MZ66-2]
DR   RefSeq; XP_016871951.1; XM_017016462.1.
DR   AlphaFoldDB; A0MZ66; -.
DR   SMR; A0MZ66; -.
DR   BioGRID; 121723; 83.
DR   IntAct; A0MZ66; 30.
DR   MINT; A0MZ66; -.
DR   STRING; 9606.ENSP00000347532; -.
DR   GlyGen; A0MZ66; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; A0MZ66; -.
DR   PhosphoSitePlus; A0MZ66; -.
DR   BioMuta; SHTN1; -.
DR   EPD; A0MZ66; -.
DR   jPOST; A0MZ66; -.
DR   MassIVE; A0MZ66; -.
DR   MaxQB; A0MZ66; -.
DR   PaxDb; A0MZ66; -.
DR   PeptideAtlas; A0MZ66; -.
DR   PRIDE; A0MZ66; -.
DR   ProteomicsDB; 45; -. [A0MZ66-1]
DR   ProteomicsDB; 46; -. [A0MZ66-2]
DR   ProteomicsDB; 47; -. [A0MZ66-3]
DR   ProteomicsDB; 48; -. [A0MZ66-4]
DR   ProteomicsDB; 49; -. [A0MZ66-5]
DR   ProteomicsDB; 50; -. [A0MZ66-6]
DR   ProteomicsDB; 51; -. [A0MZ66-7]
DR   ProteomicsDB; 6909; -.
DR   Antibodypedia; 46270; 44 antibodies from 15 providers.
DR   DNASU; 57698; -.
DR   Ensembl; ENST00000260777.14; ENSP00000260777.11; ENSG00000187164.20. [A0MZ66-5]
DR   Ensembl; ENST00000355371.9; ENSP00000347532.4; ENSG00000187164.20. [A0MZ66-1]
DR   Ensembl; ENST00000392901.10; ENSP00000376635.4; ENSG00000187164.20. [A0MZ66-8]
DR   Ensembl; ENST00000392903.3; ENSP00000376636.3; ENSG00000187164.20. [A0MZ66-4]
DR   Ensembl; ENST00000615301.4; ENSP00000480109.1; ENSG00000187164.20. [A0MZ66-2]
DR   GeneID; 57698; -.
DR   KEGG; hsa:57698; -.
DR   MANE-Select; ENST00000355371.9; ENSP00000347532.4; NM_001127211.3; NP_001120683.1.
DR   UCSC; uc001lcz.6; human. [A0MZ66-1]
DR   CTD; 57698; -.
DR   DisGeNET; 57698; -.
DR   GeneCards; SHTN1; -.
DR   HGNC; HGNC:29319; SHTN1.
DR   HPA; ENSG00000187164; Tissue enriched (brain).
DR   MIM; 611171; gene.
DR   neXtProt; NX_A0MZ66; -.
DR   OpenTargets; ENSG00000187164; -.
DR   PharmGKB; PA134973737; -.
DR   VEuPathDB; HostDB:ENSG00000187164; -.
DR   eggNOG; ENOG502QVVT; Eukaryota.
DR   GeneTree; ENSGT00510000048167; -.
DR   HOGENOM; CLU_027649_1_1_1; -.
DR   InParanoid; A0MZ66; -.
DR   OMA; NLMDAAI; -.
DR   OrthoDB; 744654at2759; -.
DR   PhylomeDB; A0MZ66; -.
DR   TreeFam; TF326250; -.
DR   PathwayCommons; A0MZ66; -.
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   SignaLink; A0MZ66; -.
DR   BioGRID-ORCS; 57698; 10 hits in 1076 CRISPR screens.
DR   ChiTaRS; SHTN1; human.
DR   GenomeRNAi; 57698; -.
DR   Pharos; A0MZ66; Tbio.
DR   PRO; PR:A0MZ66; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; A0MZ66; protein.
DR   Bgee; ENSG00000187164; Expressed in medial globus pallidus and 192 other tissues.
DR   Genevisible; A0MZ66; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0044295; C:axonal growth cone; ISS:UniProtKB.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030175; C:filopodium; ISS:UniProtKB.
DR   GO; GO:0030426; C:growth cone; ISS:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:Ensembl.
DR   GO; GO:0005875; C:microtubule associated complex; ISS:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; ISS:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019894; F:kinesin binding; IEA:Ensembl.
DR   GO; GO:0061573; P:actin filament bundle retrograde transport; ISS:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISS:UniProtKB.
DR   GO; GO:0032488; P:Cdc42 protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0060327; P:cytoplasmic actin-based contraction involved in cell motility; ISS:UniProtKB.
DR   GO; GO:0061163; P:endoplasmic reticulum polarization; ISS:UniProtKB.
DR   GO; GO:0038007; P:netrin-activated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0048812; P:neuron projection morphogenesis; ISS:UniProtKB.
DR   GO; GO:0045773; P:positive regulation of axon extension; ISS:UniProtKB.
DR   GO; GO:2001224; P:positive regulation of neuron migration; IDA:UniProtKB.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:UniProtKB.
DR   GO; GO:2000114; P:regulation of establishment of cell polarity; ISS:UniProtKB.
DR   GO; GO:0006930; P:substrate-dependent cell migration, cell extension; ISS:UniProtKB.
DR   InterPro; IPR024849; Shootin-1.
DR   PANTHER; PTHR46606; PTHR46606; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell projection; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Direct protein sequencing;
KW   Phosphoprotein; Reference proteome.
FT   CHAIN           1..631
FT                   /note="Shootin-1"
FT                   /id="PRO_0000295740"
FT   REGION          343..511
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          524..566
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          579..631
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          7..353
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        350..371
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        393..422
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        454..468
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        469..489
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        490..511
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        592..624
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2Q9"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8K2Q9"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         101
FT                   /note="Phosphoserine; by PAK1"
FT                   /evidence="ECO:0000250|UniProtKB:A0MZ67"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         473
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         487
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         496
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         506
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         532
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         537
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..412
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036497"
FT   VAR_SEQ         1..60
FT                   /note="Missing (in isoform 5 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036498"
FT   VAR_SEQ         1..37
FT                   /note="MNSSDEEKQLQLITSLKEQAIGEYEDLRAENQKTKEK -> MPRILKQ (in
FT                   isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_036499"
FT   VAR_SEQ         454..456
FT                   /note="GTL -> ASQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17030985"
FT                   /id="VSP_027050"
FT   VAR_SEQ         457..631
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10997877,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:17030985"
FT                   /id="VSP_027051"
FT   VAR_SEQ         559..631
FT                   /note="Missing (in isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027052"
FT   VAR_SEQ         623..631
FT                   /note="VRETDSSNC -> FFPFHFGFEGVLPLAGVTLSTKARDPK (in isoform
FT                   3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_027053"
FT   CONFLICT        399
FT                   /note="T -> A (in Ref. 4; AC023283)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        417
FT                   /note="I -> V (in Ref. 2; BAG52345)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   631 AA;  71640 MW;  826B88F18151228D CRC64;
     MNSSDEEKQL QLITSLKEQA IGEYEDLRAE NQKTKEKCDK IRQERDEAVK KLEEFQKISH
     MVIEEVNFMQ NHLEIEKTCR ESAEALATKL NKENKTLKRI SMLYMAKLGP DVITEEINID
     DEDSTTDTDG AAETCVSVQC QKQIKELRDQ IVSVQEEKKI LAIELENLKS KLVEVIEEVN
     KVKQEKTVLN SEVLEQRKVL EKCNRVSMLA VEEYEEMQVN LELEKDLRKK AESFAQEMFI
     EQNKLKRQSH LLLQSSIPDQ QLLKALDENA KLTQQLEEER IQHQQKVKEL EEQLENETLH
     KEIHNLKQQL ELLEEDKKEL ELKYQNSEEK ARNLKHSVDE LQKRVNQSEN SVPPPPPPPP
     PLPPPPPNPI RSLMSMIRKR SHPSGSGAKK EKATQPETTE EVTDLKRQAV EEMMDRIKKG
     VHLRPVNQTA RPKTKPESSK GCESAVDELK GILGTLNKST SSRSLKSLDP ENSETELERI
     LRRRKVTAEA DSSSPTGILA TSESKSMPVL GSVSSVTKTA LNKKTLEAEF NSPSPPTPEP
     GEGPRKLEGC TSSKVTFQPP SSIGCRKKYI DGEKQAEPVV VLDPVSTHEP QTKDQVAEKD
     PTQHKEDEGE IQPENKEDSI ENVRETDSSN C
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024